Form 4: Bicycle Therapeutics Director Sells Shares
Insider Transaction (Form 4)
Robert Charles Swanton, a Director of Bicycle Therapeutics Plc, sold 3,431 shares of common stock on October 2, 2026 for $3.47 per share.
Summary
- Open-market sale: disposed of 3,431 Ordinary Shares at $3.47 ($11,906) on October 2, 2026; holds 15,782 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $11,906 of stock on the open market.
Insider Transactions
Robert Charles Swanton — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-02 | Open-market sale | Ordinary Shares | 3,431 | $3 | $11.9K | 15,782 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-02 | Open-market sale (3,431 shares) |
Keywords
insider transaction, Form 4, BCYC, BICYCLE THERAPEUTICS PLC, bearish, Robert Charles Swanton
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.